AdvanSix (ASIX) to Release Earnings on Friday

AdvanSix (NYSE:ASIX) is scheduled to post its quarterly earnings results before the market opens on Friday, May 3rd. Analysts expect AdvanSix to post earnings of ($0.66) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

AdvanSix (NYSE:ASIX) last posted its earnings results on Friday, February 16th. The company reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.02. The business had revenue of $382.21 million for the quarter, compared to analyst estimates of $335.80 million. AdvanSix had a net margin of 3.56% and a return on equity of 6.98%. On average, analysts expect AdvanSix to post $1 EPS for the current fiscal year and $4 EPS for the next fiscal year.

AdvanSix Stock Performance

AdvanSix stock opened at $25.26 on Wednesday. The firm’s 50 day simple moving average is $27.14 and its 200 day simple moving average is $27.16. The company has a current ratio of 1.17, a quick ratio of 0.58 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $674.44 million, a PE ratio of 13.29 and a beta of 1.73. AdvanSix has a 1-year low of $23.92 and a 1-year high of $40.85.

AdvanSix Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 18th. Investors of record on Monday, March 4th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 2.53%. The ex-dividend date of this dividend was Friday, March 1st. AdvanSix’s dividend payout ratio (DPR) is presently 33.68%.

Insider Activity at AdvanSix

In related news, CEO Erin N. Kane sold 5,000 shares of the stock in a transaction on Thursday, March 28th. The shares were sold at an average price of $28.30, for a total transaction of $141,500.00. Following the transaction, the chief executive officer now owns 557,755 shares of the company’s stock, valued at approximately $15,784,466.50. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other AdvanSix news, SVP Achilles B. Kintiroglou sold 4,000 shares of the stock in a transaction on Friday, March 1st. The shares were sold at an average price of $27.80, for a total transaction of $111,200.00. Following the completion of the sale, the senior vice president now owns 42,996 shares of the company’s stock, valued at approximately $1,195,288.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Erin N. Kane sold 5,000 shares of the stock in a transaction on Thursday, March 28th. The shares were sold at an average price of $28.30, for a total transaction of $141,500.00. Following the sale, the chief executive officer now directly owns 557,755 shares of the company’s stock, valued at approximately $15,784,466.50. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 17,387 shares of company stock valued at $486,481. Insiders own 5.20% of the company’s stock.

Analysts Set New Price Targets

Separately, Stifel Nicolaus reissued a “buy” rating and issued a $40.00 price target on shares of AdvanSix in a report on Tuesday, April 9th.

AdvanSix Company Profile

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.